Por: MarketWatch Business February 01, 2023
Net profit in the fourth quarter rose to DKK13.59 billion from DKK10.89 billion, beating the DKK13.08 billion forecast by analysts in a FactSet poll. Sales rose 25% to DKK48.09 billion, against analysts' expectations of DKK47.26 billion. Global sales were driven by diabetes and obesity care sales as its glucagon-like peptide-1 drug, or GLP-1, sales increased by 18% in local currencies and obesity care sales more than doubled, partially... + full article
Fox Business USA Business October 21, 2023
Long-term use of weight loss drugs poses challenges, according to doctor Drugmakers Eli Lilly and Novo Nordisk are testing some of their most and weight loss drugs on patients as young as 6. Indiana-based Lilly is planning to test tirzepatide, sold under the brand name... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
New Data May Push Insurers to Cover Novo, Lilly Obesity Drugs | MarketWatch
The Atlantic USA Opinion October 16, 2023
Can Novo Nordisk’s success really be a problem for the Danish economy?Ben Kothe / The Atlantic; GettyOctober 16, 2023, 7:30 AM ETOver the past couple of years, no new pharmaceutical drug—perhaps no product, period—has had such widespread impact as the diabetes medication... + más
What Are the Duties of A Trustee? | Forbes
Rare silver coin from first Jewish revolt against Roman Empire discovered | Newsweek
MarketWatch USA Business August 08, 2023
The positive results represent the first concrete evidence that the new class of weight-loss drugs from Novo Nordisk (ticker: NVO) and Eli Lilly (LLY) offer substantive health benefits beyond weight reduction for overweight or obese patients without diabetes. The results will... + más
The End Of Obesity | Forbes
Use medication, surgery early to treat obesity in kids, new guidance says | Portland Press Herald
New York Post USA Business July 10, 2023
European drug-safety regulators are probing popular weight-loss drug Ozempic after patients reported that the medicine triggered thoughts of suicide and self harm. The European Medicines Agency (EMA) on Monday that a safety committee was probing Novo Nordisk-made weight-loss... + más
Does Medicare cover Ozempic? | WGN-TV
What is Ozempic? Why stars risk ‘old face’ for trendy weight-loss drug | New York Post
Fox Business USA Business May 04, 2023
Fox News medical contributor Dr. Nicole Saphier discusses the dangers of using the diabetes drug Ozempic for weight loss on 'The Big Money Show.' is cutting U.S. supply on certain dose strengths of its highly sought-after weight loss drug Wegovy due to strong demand. ... + más
Wegovy, Ozempic: The barriers to accessing these weight loss drugs | Fox Business
Forbes USA Business March 14, 2023
Topline Pharmaceutical heavyweight Novo Nordisk on Tuesday it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare companies come under increasing pressure to lower prices for the lifesaving diabetes medication.... + más
Novo Nordisk to lower insulin prices by 75% | Fox Business
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly | CNBC
CNBC USA Health March 14, 2023
In this articleNovo Nordisk Inc. NovoLog brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019.Alex Flynn Bloomberg Getty Images on Tuesday announced plans to slash the price of several insulin drugs by up to 75% in... + más
About iurex | Privacy Policy | Disclaimer |